INTEGRATED REPORT 2019


How we performed against our strategy in 2019

We use KPIs and statistics to measure our progress against our strategy.

  Growth

Geographical location and indicator Year-on-year trend 2019   2018 2017  
Life Healthcare Group  
Net debt: normalised EBITDA (ratio), debt covenant is <3.5 (2018: 3.5)1 1.96   2.73 2.55  
Interest cover (ratio), debt covenant is >4 (2017: >5.0)1 5.6   5.7 4.21  
Capital expenditure as percentage of revenue (%) 8.0   9.6 8.0  
Normalised earnings per share (EPS) (cps) 116.4   110.2 93.9  
Normalised EPS excluding amortisation (cps) 148.1   139.3 120.6  
Headline earnings per share (HEPS) (cps) 88.7   108.8 77.4  
Operating profit 3 944   3 848 3 620  
Free cash flow before transaction costs 2 342   2 237 1 928  
Southern Africa
PPDs2 2 269 756   2 251 600 2 226 337  
Occupancy (%) 69.7   69.7 70.0  
Length of stay (LOS) (days) 3.76   3.72 3.71  
Number of healthcare facilities 66   66 65  
Number of registered beds 9 136   9 055 8 983  
Number of acute facilities 49   50 50  
Number of dedicated acute rehabilitation facilities 7   7 7  
Number of dedicated mental health facilities 9   8 8  
Number of specialised maternity units 1   1 1  
Number of renal stations 329   318 303  
Number of oncology units 5   5 4  
Number of Life Esidimeni facilities 10   10 11  
Number of Life Esidimeni registered beds 3 119   3 119 3 080  
Number of Life Esidimeni PPDs 1 054 391   1 006 717 873 954  
Number of Life EHS clinics (Life occupational health) 310   301 288  
Number of lives covered through the Life EHS occupational health 210 589   211 086 222 895  
Number of Life EHS (occupational health) on-site clinics (employee wellness) 81   80 78  
Number of lives covered by Life EHS (employee wellness) 383 082   367 670 248 804  
1 Waiver consent letters were received from the relevant banks accepting the breach of covenants for a period of 13 months from the Alliance Medical acquisition date.
2 Indicator is externally assured.

  Growth

Geographical location and indicator Year-on-year
trend
2019   2018 2017  
Alliance Medical
UK
Diagnostic imaging static sites 33   33 37  
PET national contract sites – wave 1 and 2 36   34 31  
Mobile units 44   45 45  
Radiopharmacy units 4   4 4  
Diagnostic imaging static sites (scans) 298 186   281 020 323 744  
Mobile (days) 11 070   10 051 10 089  
PET-CT (scans) 96 956   83 639 72 807  
Radiopharmacy (doses) 106 960   106 123 98 464  
Mobile utilisation 82%   81% 81%  
Italy
Owned clinics 34   34 25  
Statics 8   9 13  
Radiopharmacy units 1   1 1  
MRI and CT scans – public and private 268 820   259 814 228 565  
Other – public and private (scans and other) 2 391 727   2 292 657 2 120 972  
Ireland
Operating sites 27   23 20  
MRI and CT scans – public and private (scans) 201 029   189 070 160 678  
Spain
Operating sites 11   11 11  
Molecular imaging – PET-CT (scans) 783   3 406 1 431  
Diagnostic imaging and other (scans) 97 068   102 541 101 192  
Northern Europe
Mobile and relocatable buildings 18   22 21  
Radiopharmacy units 4   4 4  
Diagnostic imaging and other (scans) 27 843   25 259 29 799  
Radiopharmacy (doses) 68 776   60 071 52 823  
Scanmed
Occupancy (%) 69   69 69  
Number of medical facilities 41   40 40  
Number of registered beds1 579   624 624  
Number of cardiac facilities 12   12 12  
1 Decrease is mainly due to new regulation on increase in number of nurses required per bed introduced January 2019 resulting on deregistration of beds across the entire industry, and a temporary closure of a ward in Blachownia due to renovation.

  Quality

Geographical location and indicator Year-on-year trend 2019   2018 2017  
Southern Africa
Quality metrics
Definitely recommend – inpatient (%) 70.70   70.70 70.00  
Definitely recommend – emergency units (%) 66.50   67.30 67.20  
Patient experience – inpatient (target >8.4) 8.4   8.4 8.1  
Patient experience – emergency units (target >8.2) 8.0   8.1 8.1  
Complaint rate (per 1 000 PPDs) 0.80   0.83 0.71  
Clinical indicators
Patient safety adverse events2,3 (per 1 000 PPDs) 2.44   2.68 2.69  
Healthcare associated infections (HAIs)3,4 (per 1 000 PPDs) 0.41   0.41 0.42  
Ventilator associated pneumonia (VAP) (per 1 000 ventilator days) 0.90   1.09 1.48  
Surgical site infections (SSI) (per 1 000 theatre cases) 1.05   0.99 0.96  
Central line associated bloodstream infections (CLABSI) (per 1 000 central lines) 0.83   0.99 0.85  
Catheter associated urinary tract infections (CAUTI) (per 1 000 catheter days on one line) 0.34   0.31 0.40  
FIMTM/FAM score5 (target >0.9) 0.84   0.90 1.00  
MHQ14 efficiency6 (average gain/PPD) (target >2.25) 2.35   2.20 2.50  
Employee adverse events (per 200 000 labour hours) 4.11   4.09 4.43  
Alliance Medical9
Patient experience (satisfied and very satisfied) 95.30%   94.40% 95.4%  
Friends and family score 94.90%   94.52% 94.2%  
Written patient complaints per 10 000 scans 3.2   4.4 4.9  
Escalated events per 10 000 scans8 0.9   0.7 n/a  
CQC/IRMER incidents per 10 000 scans 0.1   0.1 0.02  
RIDDOR reportable incidents per 10 000 scans 0   0.1 0.1  
Clinical audit: level 1 and 2 discretionary scores 0.05%   0.02% 0.06%  
Scanmed
HAI7 (%) 0.67   0.84 0.85  
Surgical site infections (SSI) (%) (SSI) 0.09   0.16 0.17  
Ventilator associated pneumonia (VAP) (%) 0.07   0.17 0.15  
Central line associated bloodstream infections (CLABSI) (%) 0.03   0.02 0.05  
Catheter associated urinary tract infections (CAUTI) (%) 0.12   0.08 0.12  
2 Patient safety adverse events: Unintended or unexpected events which could have, or did, result in harm – this includes medication, falls, pressure ulcers, procedure-related incidents, behaviour, death due to unnatural causes, burns, other patient incidents, patients absconding and other patient information incidents.
3 Indicator is externally assured.
4 HAI: Combines all the healthcare associated infections determined according to the Centre for Disease Control (CDC) guidelines – VAP, SSI, CLABSI, CAUTI and other infections associated with the hospital stay.
5 FIMTM/FAM: Weekly assessment of patients' function, while in an acute rehabilitation facility.
6 MHQ14 efficiency: Patient reported feedback in a mental health facility.
7 The calculations differ from the other areas – HAI: total number of HAI/total number of patients x 100%.
8 New category.
9 UK only.

  Efficiency

Geographical location and indicator Year-on-year trend 2019   2018 2017  
Life Healthcare Group
Cash generated from operations as percentage of EBITDA, target is >95% 103.5   99.4 93.2  
Normalised EBITDA margin (%) 22.3   23.6 24.0  
Southern Africa
Normalised EBITDA margin (%) 23.8   24.9 25.5  
Alliance Medical
Normalised EBITDA margin (%) 22.4   24.5 23.8  
Scanmed
Normalised EBITDA margin (%) 7.2   6.7 4.0  

   Sustainability

Geographical location and indicator Year-on-year trend 2019   2018 2017  
Southern Africa
Number of permanent employees 15 385   14 725 14 466  
Number of nurses enrolled in training 1 005   1 075 1 358  
ACI employees (%) 75.82   74.0 72.6  
Electricity usage1 (kWh) 135 083 292   142 934 448 148 560 938  
Water usage1 (kℓ) 765 055   1 089 999 1 246 804  
Healthcare risk waste2,3 (HCRW) (kg/PPD) 1.96   1.88 1.81  
Alliance Medical
Number of employees 2 040   2 003 1 715  
Scanmed
Number of employees 3 646   3 523 3 345  
Electricity usage1 (kWh) 5 853 701   5 994 753 4 478 604  
Water usage1 (kℓ) 32 322   43 536 33 853  
1 These figures are based on best estimates using available information.
2 Indicator is externally assured.
3 Monitoring the amount of healthcare risk waste generated by hospital – including pharmaceutical waste, anatomical waste, sharps, cytotoxic, infectious non-anatomical waste and radioactive waste.